Related Experiment Video
Updated: Jun 23, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Abstract:
The serine/threonine kinase Akt is a focal point in signaling pathways that control cell tumorigenesis and insulin resistance. In this issue, Padmanabhan et al. (2009) identify a phosphatase regulatory subunit PPTR-1 that regulates the insulin/insulin-like growth factor 1 pathway by counteracting Akt activity in worms and mammalian cells.
Insights
Researchers discovered PPTR-1, a protein that counteracts Akt activity. This finding is crucial for understanding cell tumorigenesis and insulin resistance pathways.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The serine/threonine kinase Akt is a key regulator in cellular processes, including tumorigenesis and insulin resistance.
- Understanding the regulation of Akt activity is critical for developing therapeutic strategies for related diseases.
Discussion:
- Padmanabhan et al. (2009) identified PPTR-1 as a phosphatase regulatory subunit.
- PPTR-1 was shown to counteract Akt activity in both model organisms (worms) and mammalian cells.
- This suggests a conserved mechanism for Akt regulation across species.
Key Insights:
- Identification of PPTR-1 as a novel regulator of the insulin/insulin-like growth factor 1 (IGF-1) pathway.
- Demonstration that PPTR-1 negatively regulates Akt signaling.
- Implication of PPTR-1 in controlling cellular processes linked to cancer and metabolic disorders.
Outlook:
- Further investigation into PPTR-1's precise molecular mechanisms and its role in human diseases.
- Exploring PPTR-1 as a potential therapeutic target for cancer and insulin resistance.
- Elucidating the upstream and downstream effectors of PPTR-1 in signaling networks.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

